Healthcare provider profile · identity verified

Sandra S Mcintyre, M.D.

Internal Medicine · DILLON, MT · NPI 1083695928

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	524	127
Atorvastatin Calcium	Atorvastatin Calcium	499	121
Omeprazole	Omeprazole	387	113
Tamsulosin Hcl	Tamsulosin Hcl	382	92
Losartan Potassium	Losartan Potassium	374	119
Lisinopril	Lisinopril	342	78
Gabapentin	Gabapentin	304	80
Metoprolol Succinate	Metoprolol Succinate	298	81
Amlodipine Besylate	Amlodipine Besylate	283	77
Furosemide	Furosemide	270	71
Rosuvastatin Calcium	Rosuvastatin Calcium	242	81
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	229	41
Pantoprazole Sodium	Pantoprazole Sodium	217	55
Potassium Chloride	Potassium Chloride	212	65
Tramadol Hcl	Tramadol Hcl	211	52
Trazodone Hcl	Trazodone Hcl	208	55
Escitalopram Oxalate	Escitalopram Oxalate	187	25
Duloxetine Hcl	Duloxetine Hcl	167	30
Allopurinol	Allopurinol	160	39
Montelukast Sodium	Montelukast Sodium	159	54
Simvastatin	Simvastatin	150	45
Quetiapine Fumarate	Quetiapine Fumarate	135	22
Warfarin Sodium	Warfarin Sodium	134	36
Fluticasone Propionate	Fluticasone Propionate	133	44
Metformin Hcl Er	Metformin Hcl	129	43
Oxycodone Hcl	Oxycodone Hcl	125	24
Carvedilol	Carvedilol	124	32
Hydrochlorothiazide	Hydrochlorothiazide	122	38
Celecoxib	Celecoxib	119	36
Eliquis	Apixaban	118	29
Sertraline Hcl	Sertraline Hcl	118	22
Clonazepam	Clonazepam	116	15
Baclofen	Baclofen	114	12
Bupropion Xl	Bupropion Hcl	114	28
Metoprolol Tartrate	Metoprolol Tartrate	111	36
Albuterol Sulfate Hfa	Albuterol Sulfate	106	49
Pravastatin Sodium	Pravastatin Sodium	100	28
Citalopram Hbr	Citalopram Hydrobromide	98	33
Famotidine	Famotidine	96	19
Venlafaxine Hcl Er	Venlafaxine Hcl	93	20
Zolpidem Tartrate	Zolpidem Tartrate	83	24
Lamotrigine	Lamotrigine	80	suppressed
Irbesartan	Irbesartan	79	24
Spironolactone	Spironolactone	79	29
Jardiance	Empagliflozin	77	25
Buspirone Hcl	Buspirone Hcl	74	17
Breo Ellipta	Fluticasone/Vilanterol	71	16
Alprazolam	Alprazolam	70	12
Cephalexin	Cephalexin	68	30
Estradiol	Estradiol	67	26
Fluoxetine Hcl	Fluoxetine Hcl	67	16
Xarelto	Rivaroxaban	67	15
Meloxicam	Meloxicam	62	16
Oxybutynin Chloride Er	Oxybutynin Chloride	62	19
Mirtazapine	Mirtazapine	59	12
Prednisone	Prednisone	57	27
Ropinirole Hcl	Ropinirole Hcl	57	12
Ozempic	Semaglutide	55	13
Atenolol	Atenolol	54	14
Divalproex Sodium	Divalproex Sodium	53	11
Finasteride	Finasteride	53	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	17
Levetiracetam	Levetiracetam	51	suppressed
Pregabalin	Pregabalin	51	14
Myrbetriq	Mirabegron	49	11
Methocarbamol	Methocarbamol	48	14
Metformin Hcl	Metformin Hcl	47	13
Alendronate Sodium	Alendronate Sodium	46	17
Propranolol Hcl	Propranolol Hcl	44	15
Olanzapine	Olanzapine	43	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	12
Benazepril Hcl	Benazepril Hcl	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	30
Valacyclovir	Valacyclovir Hcl	36	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	11
Lorazepam	Lorazepam	34	12
Venlafaxine Hcl	Venlafaxine Hcl	34	suppressed
Dutasteride	Dutasteride	33	suppressed
Ezetimibe	Ezetimibe	33	13
Midodrine Hcl	Midodrine Hcl	33	suppressed
Nystatin	Nystatin	33	24
Synthroid	Levothyroxine Sodium	33	11
Ventolin Hfa	Albuterol Sulfate	33	14
Lactulose	Lactulose	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	13
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	28	suppressed
Prazosin Hcl	Prazosin Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Sotalol	Sotalol Hcl	26	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	25	suppressed
Methadone Hcl	Methadone Hcl	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Sucralfate	Sucralfate	24	suppressed
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Pentoxifylline	Pentoxifylline	23	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Digoxin	Digoxin	22	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	22	suppressed
Olanzapine Odt	Olanzapine	22	suppressed
Azithromycin	Azithromycin	21	11
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Risperidone	Risperidone	21	suppressed
Dexamethasone	Dexamethasone	20	13
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	20	suppressed
Divalproex Sodium Er	Divalproex Sodium	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Diazepam	Diazepam	19	11
Premarin	Estrogens, Conjugated	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Chlorthalidone	Chlorthalidone	16	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Klor-Con M10	Potassium Chloride	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Fentanyl	Fentanyl	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Acebutolol Hcl	Acebutolol Hcl	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Enbrel	Etanercept	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Letrozole	Letrozole	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Progesterone	Progesterone, Micronized	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error